A 4-year-old boy from rural India presents with an abdominal mass. Imaging shows a left-sided renal tumor with involvement of the renal vein and inferior vena cava. Urine catecholamine metabolites are normal. Which feature would most reliably distinguish this as Wilms tumor rather than neuroblastoma?

Explanation

## Syndromic Association: The Most Reliable Distinguisher ### Why Option B is Correct **Key Point:** The question asks which feature would **most reliably distinguish** Wilms tumor from neuroblastoma. Association with hemihypertrophy and Beckwith-Wiedemann syndrome (BWS) is a hallmark of Wilms tumor and is **not** seen with neuroblastoma. This syndromic association is a textbook-level, high-yield distinguishing feature that is specific to Wilms tumor. ### Why Option A (Renal Vein / IVC Invasion) is Incorrect as the "Most Reliable" Distinguisher While it is true that Wilms tumor can invade the renal vein and IVC (and neuroblastoma does not arise from renal parenchyma), the stem **already tells us** the tumor is a "left-sided renal tumor" — i.e., the renal origin is already established by imaging. The question asks what would **distinguish** the two tumors, implying we need a feature that is specific to Wilms tumor and not shared with neuroblastoma. Renal vein invasion is a consequence of renal origin, not an independent distinguishing feature when renal origin is already given. Furthermore, neuroblastoma can encase and compress the renal vein without arising from it, making this a less reliable standalone discriminator in clinical practice. ### Comparative Features: Wilms Tumor vs. Neuroblastoma | Feature | Wilms Tumor | Neuroblastoma | |---------|-------------|---------------| | **Syndromic associations** | BWS, hemihypertrophy, WAGR, Denys-Drash | None (sporadic) | | **Primary site** | Renal parenchyma | Adrenal medulla, sympathetic chain | | **Urinary catecholamines** | Normal | Elevated (VMA/HVA) in ~90% | | **Renal vein invasion** | Common | Not primary; can encase vessels | | **Anaplasia** | Seen in ~5–10% (unfavorable histology) | Not a defining feature | | **LOH 16q** | Wilms-specific prognostic marker | Not characteristic | ### Clinical Pearl **Clinical Pearl:** Beckwith-Wiedemann syndrome (macroglossia, omphalocele, gigantism, hemihypertrophy) carries a ~5–10% lifetime risk of Wilms tumor. WAGR syndrome (Wilms, Aniridia, Genitourinary anomalies, intellectual disability/Retardation) is associated with WT1 deletion at 11p13. These syndromic associations are **pathognomonic for Wilms tumor** and are never seen with neuroblastoma — making them the most reliable clinical distinguisher. ### High-Yield Distinction **High-Yield:** When asked to distinguish Wilms tumor from neuroblastoma, the syndromic associations (BWS, hemihypertrophy, WAGR, Denys-Drash) are the most reliable and specific features for Wilms tumor. Elevated urinary catecholamines (VMA/HVA) are the most reliable marker for neuroblastoma. The stem already confirms normal catecholamines, further supporting Wilms tumor. [cite: Robbins & Cotran Pathologic Basis of Disease, 10e, Ch 10; Nelson Textbook of Pediatrics, 21e]